Could dopamine be a silent killer?
作者信息
Azarov Nick, Milbrandt Eric B, Pinsky Michael R
机构信息
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
出版信息
Crit Care. 2007;11(1):302. doi: 10.1186/cc5146.
Abstract
摘要
相似文献
1
Could dopamine be a silent killer?多巴胺会是一个隐匿的杀手吗？
Crit Care. 2007;11(1):302. doi: 10.1186/cc5146.
2
Tobacco use by Native North Americans: sacred smoke and silent killer. [Review of: Winter, J.C., ed., Tobacco use by Native North Americans: sacred smoke and silent killer. Norman: U. of Oklahoma Pr., 2000].北美原住民的烟草使用：神圣的烟雾与无声的杀手。[评介：温特，J.C. 编，《北美原住民的烟草使用：神圣的烟雾与无声的杀手》。诺曼：俄克拉荷马大学出版社，2000年]
Pac Northwest Q. 2004;96(1):44-5.
3
Tobacco use by Native North Americans: sacred smoke and silent killer. [Review of: Winter, J.C., ed., Tobacco use by Native North Americans: sacred smoke and silent killer. Norman: U. of Oklahoma Pr., 2000].北美原住民的烟草使用：神圣的烟雾与无声的杀手。[评：温特，J.C. 编，《北美原住民的烟草使用：神圣的烟雾与无声的杀手》。诺曼：俄克拉荷马大学出版社，2000年]
Am Indian Cult Res J. 2001;25(3):224-6.
4
Silent pituitary adenomas.无功能性垂体腺瘤
Endocrinol Metab Clin North Am. 2015 Mar;44(1):79-87. doi: 10.1016/j.ecl.2014.11.001. Epub 2014 Nov 6.
5
Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.嵌合多巴胺D2/α1B受体与磷脂酶C途径的组成型偶联：抗精神病药物从反向激动到沉默拮抗作用
J Pharmacol Exp Ther. 2003 Jan;304(1):380-90. doi: 10.1124/jpet.102.040535.
6
[A silent killer: the primary hypertension non complicated].无声杀手：原发性单纯性高血压
Rev Med Inst Mex Seguro Soc. 2011 May-Jun;49(3):233-5.
7
Inflammation, a silent killer in cancer is not so silent!炎症，癌症中的沉默杀手并非如此悄无声息！
Curr Opin Pharmacol. 2009 Aug;9(4):347-50. doi: 10.1016/j.coph.2009.06.018. Epub 2009 Aug 9.
8
Mating-type locus control of killer toxins from Kluyveromyces lactis and Pichia acaciae.乳酸克鲁维酵母和阿拉伯胶毕赤酵母杀伤毒素的交配型位点控制
FEMS Yeast Res. 2006 May;6(3):404-13. doi: 10.1111/j.1567-1364.2005.00006.x.
9
Hypertension; the silent killer.高血压；无声的杀手。
J Pract Nurs. 1973 Nov;23(11):23-5.
10
Carbon monoxide: a silent killer.一氧化碳：无声杀手。
Harv Mens Health Watch. 2000 Nov;5(4):7-8.
引用本文的文献
1
Pharmacologic agents for acute hemodynamic instability: recent advances in the management of perioperative shock- a systematic review.用于急性血流动力学不稳定的药物制剂：围手术期休克管理的最新进展——一项系统评价
Ann Card Anaesth. 2015 Oct-Dec;18(4):543-54. doi: 10.4103/0971-9784.166464.
本文引用的文献
1
Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.休克时给予多巴胺会影响预后吗？急重症患者脓毒症发生率（SOAP）研究结果
Crit Care Med. 2006 Mar;34(3):589-97. doi: 10.1097/01.CCM.0000201896.45809.E3.
2
Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients.多培沙明、多巴酚丁胺或多巴胺对高危手术患者血清催乳素和促甲状腺激素浓度的影响。
Intensive Care Med. 2004 Jun;30(6):1127-33. doi: 10.1007/s00134-004-2279-4. Epub 2004 May 11.
3
The effect of clustering of outcomes on the association of procedure volume and surgical outcomes.结局聚集对手术量与手术结局关联的影响。
Ann Intern Med. 2003 Oct 21;139(8):658-65. doi: 10.7326/0003-4819-139-8-200310210-00009.
4
Rare outcomes, common treatments: analytic strategies using propensity scores.罕见结局，常见治疗：使用倾向评分的分析策略。
Ann Intern Med. 2002 Oct 15;137(8):693-5. doi: 10.7326/0003-4819-137-8-200210150-00015.
5
Adjustments for center in multicenter studies: an overview.多中心研究中的中心调整：概述
Ann Intern Med. 2001 Jul 17;135(2):112-23. doi: 10.7326/0003-4819-135-2-200107170-00012.
6
Effect of norepinephrine on the outcome of septic shock.去甲肾上腺素对感染性休克结局的影响。
Crit Care Med. 2000 Aug;28(8):2758-65. doi: 10.1097/00003246-200008000-00012.
7
Anterior pituitary function during critical illness and dopamine treatment.危重病及多巴胺治疗期间的垂体前叶功能
Crit Care Med. 1996 Sep;24(9):1580-90. doi: 10.1097/00003246-199609000-00024.
8
Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?去甲肾上腺素还是多巴胺用于治疗高动力型感染性休克？
Chest. 1993 Jun;103(6):1826-31. doi: 10.1378/chest.103.6.1826.
9
Ulf von Euler--norepinephrine and the Nobel Prize.
Mayo Clin Proc. 1995 Mar;70(3):273. doi: 10.4065/70.3.273.
10
Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients.
Crit Care Med. 1992 Dec;20(12):1644-9. doi: 10.1097/00003246-199212000-00007.
Zotero 插件